Liraglutide is a GLP-1 receptor agonist, a once-daily injectable medication used to improve blood sugar control in adults with type 2 diabetes. It also reduces cardiovascular risk in those with heart disease. At higher doses, it’s prescribed for chronic weight management in individuals with obesity or overweight who have weight-related conditions. It works by enhancing insulin release and promoting satiety.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends